Company Filing History:
Years Active: 2023
Title: Min Jea Shin: Innovator in Protein Transduction Domains
Introduction
Min Jea Shin is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of protein transduction domains. His innovative work has the potential to enhance the delivery of therapeutic agents into living cells.
Latest Patents
Min Jea Shin holds a patent for a protein transduction domain, a fusion compound containing the same, and a pharmaceutical composition that utilizes this fusion compound. The patent describes a GK1 peptide comprising 18 amino acids, which has been modified to improve its efficiency in penetrating high-molecular-weight materials such as proteins. This advancement allows for smoother delivery of these materials into living bodies, including cells, tissues, or blood. The fusion compound, oligonucleotide, or vector derived from this research can be applied in pharmaceutical compositions aimed at preventing or treating various diseases.
Career Highlights
Min Jea Shin is associated with Genesen Co., Ltd., where he continues to push the boundaries of biotechnological research. His work has garnered attention for its potential applications in medicine and therapeutic development.
Collaborations
He collaborates with notable colleagues, including Soo-Young Choi and Jin-Seu Park, who contribute to the innovative research environment at Genesen Co., Ltd.
Conclusion
Min Jea Shin's contributions to the field of protein transduction domains exemplify the impact of innovative research in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical applications.